Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 690-694    DOI: 10.12891/ceog4753.2019
Original Research Previous articles | Next articles
Lipid indices in women blood serum before and after the procedure of removal of mature ovarian teratoma
M. Karmowski1, †, K. A. Sobiech2, †, J. Majda3, †, P. Rubisz1, †*(), A. Karmowski1, †, L. Hirnle1, †
1Department of Gynecology and Obstetrics, Wroclaw Medical University, Wrocław, Poland
2Department of Human Biology, University School of Physical Education in Wrocław, Wrocław, Poland
3Department of Laboratory Diagnostics, IV Military Hospital, Wrocław, Poland
Download:  PDF(589KB)  ( 213 ) Full text   ( 10 )
Export:  BibTeX | EndNote (RIS)      

Purpose of Investigation: The aim of this study was to find new markers for detection of ovarian neoplasms. Authors decided to compare the lipid indicies in the blood serum of patients undergoing surgery treatment of mature ovarian teratomas. Lack of data on this subject in accessible literature was a stimulating factor for this study. Materials and Methods: The examinations covered two groups of women, each with 32 persons. Fasting blood serum gained from blood samples was analysed, marking before the surgical procedure, on the 7th day, six and 12 months after the procedure. Correlations between lipid indices changes HDL/TCH, HDL/LDL, and ApoA1/ApoB was analysed with use of Spearman correlation test. Results: In all parameters of the lipid metabolism and lipid indices, similar direction of changes - that is a trend direction, has been observed. Conclusions: Lipid indices showed their usefulness in preoperational monitoring, the effectiveness of treatment, and postoperative monitoring of mature ovarian teratomas.

Key words:  Lipid index      Ovarian neoplasm      Ovarian teratoma      Blood serum      Lipid changes     
Published:  10 October 2019     
*Corresponding Author(s):  P. RUBISZ     E-mail:
About author:  Contributed equally.

Cite this article: 

M. Karmowski, K. A. Sobiech, J. Majda, P. Rubisz, A. Karmowski, L. Hirnle. Lipid indices in women blood serum before and after the procedure of removal of mature ovarian teratoma. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 690-694.

URL:     OR

[1] S.H. Park, J. Lim, K.T. Lim, K.H. Choi, S.M. Yoon, H.J. Chung. Ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis, a type of limbic encephalitis: a review of the literature and a case report in korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 774-780.
[2] Y.A. Kim. Mature cystic teratoma of the uterus presenting as an endometrial polyp in a patient with a history of ovarian mature cystic teratoma with gliomatosis peritonei and ovarian endometriosis: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 800-804.
[3] S.Y. Jung, H.Y. Cho, S.H. Lee, S. Lim, K.B. Lee. Pregnancy outcomes of a giant primary ovarian leiomyoma in the first trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 135-138.
[4] Y.-S. Kim, J.-Y. Hwang, T.-H. Kim, E.-G. Lee, H.-H. Lee. Genome-wide association study of recurrent endometriosis related with ovarian cancer[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 553-559.
[5] S. Matsuoka, H. Tsujioka, M. Ando, Y. To, T. Koyanagi, H. Kondo, F. Eguchi. Anti-N-methyl-D-aspartate receptor encephalitis associated with a tiny ovarian teratoma diagnosed by exploratory laparoscopy: report of two cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 305-308.
[6] Xi Yang, Ke Ma, Yiting Meng. Parasitic teratoma in the pouch of Douglas[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 952-956.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .